engleski

The 6th FESCC Continuous Postgraduate Course in Clinical Chemistry : New trends in diagnosis, monitoring and management of metabolic syndrome

The Croatian Society of Medical Biochemists and Slovenian Association for Clinical Chemistry, together with the Forum of the European Societies of Clinical Chemistry (FESCC) - IFCC in Europe have organized the sixth in a series of postgraduate weekend courses under the auspices of IFCC. The Course entitled “ New Trends in Classification, Monitoring and Management of Metabolic Syndrome” promotes continuous postgraduate education of professionals in clinical chemistry and laboratory medicine, and ensures the laboratory knowledge harmonization, this time on metabolic syndrome in particular. The initial description and several definition of metabolic syndrome using different sets of criteria reflect contrasting views on pathogenic mechanisms. The use of these definitions of metabolic syndrome in diverse populations has resulted in different prevalence rates, inconsistencies and confusion in research and clinical practice. Therefore in 2005 the International Diabetes Federation (IDF) has proposed a new word wide definition of metabolic syndrome. In this specialized FESCC Course, renowned experts from European countries try to cover the clinical and laboratory aspects of metabolic syndrome. This Handbook contains the material prepared by these experts especially for this Course. The integrated knowledge of the authors, experts in different fields, is intended to provide the reader with optimal information. The Handbook contents are divided into three chapters according to the Course program. The chapter BASIC CONCEPTS covers topics such as Pathophysiology of Metabolic Syndrome (MS), Prediabetes and MS, Genetic Susceptibility to the MS. In the chapter RISK ASSESMENT, Dislipidemia, Coronary Disease, Insulin Resistance andMS, Pro-inflamatory and thrombotic factors are described. The last chapter is dedicated to DIAGNOSTIC EXACTANESS OF BIOCHEMICAL MARKERS where Evidence Based Laboratory Medicine, Hypertension and Metabolic Syndrome, Approach to the treatment of MS are presented.

metabolic syndrome; dyslipidemia; coronary disease; insulin resistance; prothrombotic factors; hypertension

nije evidentirano